Brilleman Samuel L, Gravelle Hugh, Hollinghurst Sandra, Purdy Sarah, Salisbury Chris, Windmeijer Frank
Centre for Academic Primary Care, University of Bristol, United Kingdom.
Centre for Health Economics, University of York, United Kingdom.
J Health Econ. 2014 May;35(100):109-22. doi: 10.1016/j.jhealeco.2014.02.005. Epub 2014 Mar 2.
Models of the determinants of individuals' primary care costs can be used to set capitation payments to providers and to test for horizontal equity. We compare the ability of eight measures of patient morbidity and multimorbidity to predict future primary care costs and examine capitation payments based on them. The measures were derived from four morbidity descriptive systems: 17 chronic diseases in the Quality and Outcomes Framework (QOF); 17 chronic diseases in the Charlson scheme; 114 Expanded Diagnosis Clusters (EDCs); and 68 Adjusted Clinical Groups (ACGs). These were applied to patient records of 86,100 individuals in 174 English practices. For a given disease description system, counts of diseases and sets of disease dummy variables had similar explanatory power. The EDC measures performed best followed by the QOF and ACG measures. The Charlson measures had the worst performance but still improved markedly on models containing only age, gender, deprivation and practice effects. Comparisons of predictive power for different morbidity measures were similar for linear and exponential models, but the relative predictive power of the models varied with the morbidity measure. Capitation payments for an individual patient vary considerably with the different morbidity measures included in the cost model. Even for the best fitting model large differences between expected cost and capitation for some types of patient suggest incentives for patient selection. Models with any of the morbidity measures show higher cost for more deprived patients but the positive effect of deprivation on cost was smaller in better fitting models.
个体初级保健成本决定因素模型可用于确定向医疗机构支付的人头费,并检验横向公平性。我们比较了八项患者发病率和多病共存情况的指标预测未来初级保健成本的能力,并基于这些指标研究人头费支付情况。这些指标源自四个发病率描述系统:质量与结果框架(QOF)中的17种慢性病;查尔森方案中的17种慢性病;114个扩展诊断组(EDC);以及68个调整临床组(ACG)。这些指标应用于174家英国医疗机构中86100名个体的患者记录。对于给定的疾病描述系统,疾病计数和疾病虚拟变量集具有相似的解释力。EDC指标表现最佳,其次是QOF和ACG指标。查尔森指标表现最差,但与仅包含年龄、性别、贫困和医疗机构效应的模型相比仍有显著改善。线性模型和指数模型对不同发病率指标的预测能力比较相似,但模型的相对预测能力因发病率指标而异。根据成本模型中包含的不同发病率指标,个体患者的人头费支付差异很大。即使对于拟合度最佳的模型,某些类型患者的预期成本和人头费之间的巨大差异也表明存在患者选择激励因素。包含任何发病率指标的模型都显示,贫困程度较高的患者成本更高,但在拟合度较好的模型中,贫困对成本的正向影响较小。